Skip to main content

Table 1 Preoperative Characteristics

From: Evaluation of preoperative intra-aortic balloon pump in coronary patients with severe left ventricular dysfunction undergoing OPCAB surgery: early and mid-term outcomes

Variables

Group A (n = 115)

N (%)

Group B (n = 106)

N (%)

P value

Female sex

42(36.5)

32 (30.2)

0.42

Age > 65 years

78 (67.8)

80 (75.5)

0.11

Symptom status(stable)

66 (57.4)

70 (66.0)

0.65

Diabetes

35 (30.4)

36 (34.0)

0.77

Hypertension

70 (60.9)

79 (74.5)

0.12

Hypercholesterolemia

85 (73.9)

76 (71.7)

0.88

Smoking

86 (74.8)

72(67.9)

0.61

Chronic Renal dysfunction

4 (3.5)

3 (2.8)

0.08

Chronic Gastritis

9 (7.8)

10 (9.4)

0.11

COPD

16 (13.9)

18 (17.0)

0.47

Peripheral vascular disease

7(6.1)

5 (4.7)

0.21

MI

73 (63.5)

79 (74.5)

0.06

Angina (CCS III/IV)

95 (82.6)

84 (79.2)

0.21

Dyspnea (NYHA III/IV)

55(47.8)

42 (39.6)

0.18

Redo CABG

2 (1.7)

1(0.9)

0.07

Prior CVA

5 (4.3)

3 (2.8)

0.11

BMI > 30 kg/m2

45 (39.1)

35 (33.0)

0.45

Aspirin<10 days

96 (83.5)

78(73.6)

0.17

Previous failed PTCA

8 (7.0)

8 (7.5)

0.64

Parsonnet score >10

73 (63.5)

73 (68.9)

0.37

Left main disease

20 (17.2)

21 (19.8)

0.58

Mean Diseased vessels

3.20 ± 0.36

3.42 ± 0.52

0.85

Mean EuroSCORE

12.58 ± 3.05

13.37 ± 3.13

0.26

Mean LVEF(%)

29.62 ± 5.32

30.04 ± 4.27

0.36

  1. CCS = Canadian Cardiovascular Society score; COPD = chronic obstructive pulmonary disease; MI = myocardial infarction; CVA = cerebrovascular accident; GI = gastrointestinal; BMI = body mass index; PTCA = percutaneous transluminal coronary angioplasty;